Quantitation of immune deposit formation in glomeruli and correlation with immunohistologic and functional changes has been accomplished only in models of antiglomerular basement membrane antibody-induced nephritis, or indirectly in immune complex disease by measuring radiolabeled antigen deposition. The kinetics of subepithelial immune deposit formation and the relationship between the quantity of antibody deposited and proteinuria are defined here for the first time in an established model of membranous immune complex nephritis (passive Heymann nephritis) induced by a single intravenous injection of 125 I-labeled sheep immunoglobulin (Ig)G antibody to rat tubular brush border antigen (Fx1A). Measurement of antibody deposition in glomeruli (GAb) isolated from rats injected with 10 mg of anti-Fx1A demonstrated a mean of 12 µg GAb in 4 h, which increased linearly to 48 µg in 5 d. GAb represented only 20 and 44% of total kidney antibody binding at these times. Proteinuria occurred only after 4-5 d of antibody deposition in rats with total kidney antibody binding exceeding ~200 µg/2 kidneys. Steroid treatment and vasoactive amine blockade did not significantly alter the quantity or localization of immune deposits. It was also demonstrated that isolated rat glomeruli specifically bound nephritogenic quantities of anti-Fx1A in vitro within hours. Analysis of the quantitative aspects of glomerular antibody deposition in vivo and glomerular antibody binding in vitro provides additional evidence that subepithelial immune […] Find the latest version:
A B S T R A C T Quantitation of immune deposit formation in glomeruli and correlation with immunohistologic and functional changes has been accomplished only in models ofanti-glomerular basement membrane antibody-induced nephritis, or indirectly in immune complex disease by measuring radiolabeled antigen deposition. The kinetics of subepithelial immune deposit formation and the relationship between the quantity of antibody deposited and proteinuria are defined here for the first time in an established model of membranous immune complex nephritis (passive Heymann nephritis) induced by a single intravenous injection of 125I-labeled sheep immunoglobulin (Ig)G antibody to rat tubular brush border antigen (FxlA). Measurement of antibody deposition in glomeruli (GAb) isolated from rats injected with 10 mg of antiFxlA demonstrated a mean of 12 ,ug GAb in 4 h, which increased linearly to 48 ,ug in 5 d. GAb represented only 20 and 44% of total kidney antibody binding at these times. Proteinuria occurred only after [4] [5] d of antibody deposition in rats with total kidney antibody binding exceeding -200 j,g/2 kidneys. Steroid treatment and vasoactive amine blockade did not significantly alter the quantity or localization of immune deposits. It was also demonstrated that isolated rat glomeruli specifically bound nephritogenic quantities of anti-FxlA in vitro within hours. Analysis of the quantitative aspects of glomerular antibody deposition in vivo and glomerular antibody binding in vitro pro-vides additional evidence that subepithelial immune deposits in passive Heymann nephritis may form in situ by reaction of free antibody with antigenic constitutents of the normal rat glomerulus. The observed kinetics ofdeposit formation differ markedly from those in anti-glomerular basement membrane disease and suggest a role for factors in addition to antigen-antibody interaction in determining this unique pattern of glomerular immune deposit formation.
INTRODUCTION
Membranous nephropathy is a well-characterized glomerular disease in which the gradual accumulation of deposits of immunoglobulin and complement in a discontinuous granular pattern in the subepithelial space results in a marked increase in capillary permeability with proteinuria and nephrotic syndrome (1, 2) . Unlike most other types of glomerulonephritis mediated by immune deposits, in membranous nephropathy there are no significant histologic inflammatory changes early in the disease and renal function is generally not compromised when proteinuria begins. Although the interpretation of several studies has been that deposits of immunoglobulin in a membranous pattern result from glomerular trapping of low molecular weight immune complexes formed in the circulation (3) (4) (5) (6) , evidence obtained from recent studies in a rat model that resembles membranous nephropathy suggests that these deposits may form in situ as a result of free antibody interacting with antigens normally present or fixed in the glomerular capillary wall (7) (8) (9) (10) (11) . This hypothesis would predict that the kinetics of glomerular antibody deposition and the functional consequences thereofshould resemble those described in models of nephritis mediated by antibody to glomerular basement membrane antigens (nephrotoxic nephritis) in which glomerular antibody deposition is immediate (12) and induces an acute inflamma-tory lesion apparently similar to the experimental Arthus reaction accompanied by significant alterations in renal function (13, 14) . Whether the marked differences in these two types of glomerular lesions reflect differences in the mechanisms of deposit formation or qtuantitative differences in the rate or amount of antibody deposition is unclear.
In passive Heymann nephritis (PHN),' rats injected with heterologous antibody to an antigen derived from the brush border of proximal tubular epithelial cells (FxIA) develop subepithelial deposits of immunoglobulin (Ig)G and host complement and a glomerular lesion indistinguishable by immunofluorescence (IF) and electron microscopy (EM) from membranous nephropathy in man (8) (9) (10) (11) 15) . The capacity to induce subepithelial deposits by a single injection of antibody has afforded the opportunity to measure quantitatively the kinetics of glomerular immune deposit formation and to correlate glomerular antibody deposition with proteinuria for the first time in an experimental model of membranous nephropathy. Although some quantitative data on glomerular subepithelial immune deposits has been obtained in the serumii sickness models in rabbits, these studies have measured only antigen deposition (16) . All information currently available relating antibody deposits in glonmeruli to alterations in glomerular histology and ftinction has been derived from studies in nephrotoxic nephritis models (12) (13) (14) .
These studies provide the first quantitative information on the rate and quantity of antibody deposition in experimental membranous nephropathy as they relate to changes in capillary wall permeability and define a unique time-course of glomerular immune deposit formationi, which may explain some of the unique features of this common glomerular disease. In vitro stu(lies demonstrate that isolated rat glomeruli can bind sufficient antibody to account for the deposits seen in vivo in proteinuric rats. Moreover, in vivo measurements of anitibody binding after steroid therapy and vasoactive amine blockade show no effect of these manipulationis on deposit formation.
METHODS
Preparatiotn of antibody to rat FxlA and gloinerular basement membrane (GBM) and itndcuction of PHN Fx1A was prepared from fresh, saline-perfused, rat renal cortices as described by Edgington et al. (17) Fx1A in complete Freund's adjuvant (Difco Laboratories, Detroit, Mich.) over a 2-mo period. Serum collected 2 wk after the last immunization was heat-inactivated (56°C, 30 min) and absorbed with pooled rat serum, leukocytes, erythrocytes, and platelets as described (7) . To avoid contaminating the radiolabeled IgG with rat IgG, absorption with rat serum was performed after radiolabeling (see below). The IgG fraction was isolated from a 50% ammonium sulfate precipitate by ion-exchange chromatography on DEAE-Sephadex (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.). AntiFxlA IgG, at a concentration of 10 mg/ml, was not reactive with rat plasma by micro-Ouchterlony (18) and immunoelectrophoresis (19) , but made two precipitin lines against a 10 mg/ml suspension of FxlA in saline (17, 20) . By indirect IF, the antibody reacted with rat proximal tubular epithelial cell brush border to a dilution of 1 x 106.
Antibody to rat GBM was prepared by immunizing sheep with whole rat glomeruli as described (21) . IgG isolation, absorption, and radiolabeling were carried out exactly as described for anti-FxlA. A dose of 10 mg of anti-GBM IgG administered to normal rats induced 4+ linear staining for IgG on the GBM, no extraglomerular deposits by IF, and urine protein excretion of about 200 mg/d in the 24-h period after injection. Normal sheep IgG was isolated from normal sheep serum and radiolabeled as described below. Intravenous administration to normal rats produced no renal deposits by IF Experiment B. Within Bowman's capsule of some rat glomeruli are proximal tubular epithelial cells with brush borders that are reactive with anti-Fx1A. To evaluate any possible effect of these cells on in vitro antibody binding, the experiment described above was repeated using a second preparation of fresh glomeruli, which still contained <1% nonglomerular elements, but only 7% of the glomeruli were encapsulated. These glomeruli were prepared from the kidneys of Charles River rats weighing 350-400 g using Nos. 170 and 200 sieves and the addition of two low speed centrifugations (120 g for 90 s) of the glomerular preparation during washing. In this second study, five tubes containing equal numbers of intact glomeruli were incubated with labeled anti-FxlA and with normal sheep IgG.
To assess the distribution of bound IgG, aliquots of isolated glomeruli that had previously been incubated for 21 Disappearance kinetics of anti-FxlA and normal sheep IgG from rat blood and whole rats PNH was induced in 16 rats by injection of 10 mg i.v. of labeled anti-FxlA and the disappearance kinetics was determined by measuring the concentration of anti-FxlA IgG in rat blood at 1, 4, and 24 h, and daily for 5 d. A second group of 19 rats was given 10 mg i.v. of labeled normal sheep IgG and the disappearance kinetics measured at the same time intervals. To assess the effect of anti-FxlA on the disappearance kinetics of normal sheep IgG, a third group of nine rats was given 10 mg i.v. of unlabeled anti-FxIA IgG with a trace dose of labeled normal sheep IgG and the disappearance kinetics was measured at 1, 24, and 72 h. The concentration of sheep IgG in rat blood (microgram per milliliter) was calculated from the radioactivity of 100 ul of rat blood (corrected for background and decay) drawn from the tail and expressed as a percentage of the initial concentration. The initial concentration was calculated from the administered dose of IgG divided by the rat blood volume (estimated at 7% of body weight) (23) rather than by direct measurement because of difficulty obtaining blood immediately from antibody injected rats. All rats were given 0.005 g/100 ml KI and 0.45 g/100 ml NaCl in their drinking water to block thyroid uptake and facilitate the urinary excretion of free 125I.
Alterations in plasma volume were calculated from measurements of the hematocrit on blood samples taken before antibody injection and 1 and 4 h afterward. Persistence of free circulating anti-FxlA in blood taken at each time interval was determined by indirect IF on normal rat kidney.
Whole-body radioactivity was measured in a whole-animal Packard gamma spectrometer, model 3002 immediately after injection of radiolabeled anti-FxlA or normal sheep IgG and daily for 5 d. The amount of sheep IgG retained by each offour rats in both groups was determined from the whole body radioactivity at each time interval and expressed as a percentage of the activity measured immediately after injection.
Kinetics of total kidney antibody binding (TKAb) in PHN PHN was induced in 16 rats by the injection of 10 mg i.v. of labeled anti-FxlA and groups of three to four were killed at 1 and 4 h, and 1, 2, and 5 d later for determination of the TKAb. Under ether anesthesia, the abdomen was opened, 100 U i.v. heparin injected, the aorta ligated immediately above and below the renal arteries, and the kidneys gently perfused via the superior mesenteric artery and aorta with 60 ml heparinized saline over 3-5 min. The kidneys were then removed, stripped of their capsules and pedicles, and TKAb determined from kidney radioactivity in each rat. In a pilot study to evaluate this procedure, washed homogenates of six kidneys from rats injected with labeled anti-FxlA were found to contain 87.3±4.3% of the kidney bound radioactivity, whereas the activity in the washes was 91.5±5.2% TCA precipitable. To 
Measurement of glomerular bound antibody (GAb)
To determine the amount of TKAb specifically bound in glomeruli, glomeruli were isolated individually from the perfused kidneys of each rat by differential sieving as described for experiment A above, counted, and their radioactivity measured. The GAb of each rat was calculated from the equation: GAb (micrograms per two kidneys) = counts per minute in glomeruli x 76,000/number of glomeruli x specific activity, where 76,000 = number of glomeruli in two rat kidneys (24, 25) . When glomeruli were isolated from the perfused kidneys of rats given normal sheep IgG, nonspecific contamination of glomeruli with sheep IgG was found to be <1 g.g/2 kidneys at all time intervals and has therefore been disregarded in the determination of GAb.
Relationship of antibody deposition to the development of proteinuria PHN was induced in 38 rats bv intravenous injection of labeled anti-FxlA IgG in doses varying from 5 to 35 mg.
Urine protein excretion was measured on 24-h urine specimens collected from all rats before killing at day 5 and TKAb was measured in each rat. (28) . The effects of steroids acnd vasoactive aminie blockers were examined by analysis of variance (28) . Differences were regarded as significant wheni P < 0.05.
Unless otherwise stated, all values are expressed as the mean1 -ISD.
RESULTS
Localizationi of kidniey deposits ini PHN iniduced wvith labeled aniti-FxJA. The glomerular lesion on day 1-5 was identical in rats injected with labeled anti-FxlA anid nonradiolabeled antibody and was identical to fiindinigs in this model descril)ed in detail elsewhere (10, 11 glomeruli bound almost twice as much anti-GBM IgG as anti-FxlA IgG (P < 0.001), and sonication produced an increase of 11% in the binding of anti-GBM IgG (P < 0.001).
The amount ofanti-FxlA IgG bound in experiment B (Table I) (Fig. 1) . The exact site of binding could not be identified by IF. Anti-GBM IgG was seen in a linear pattern on the GBM, whereas normal sheep IgG showed very weak diffuse staining of glomeruli (Fig.  1) . Glomeruli incubated in buffer alone and fresh glomeruli failed to show specific fluorescence after staining with conjugated anti-sheep IgG. Indirect IF of anti-FxlA IgG on cryostat sections of normal rat kidney produced intense staining of proximal tubular brush borders and faint, diffuse glomerular capillary wall staining without distinct granularity.
Disappearance kinetics of normal sheep IgG and anti-FxJA from rat blood and whole rats. After injection of 10 mg of labeled anti-FxlA or normal sheep IgG, an exponential decline in the concentration of sheep IgG in rat blood was observed (Fig. 2) . The initial loss of anti-FxlA IgG from the circulation was significantly greater than that of normal IgG. At 1 h after injection, the concentration of sheep IgG in rat blood represented 37.9±6.5% (n = 6) ofthe initial concentration in rats given anti-FxlA as compared to 47.8
±5.2% (n = 4) in the group given normal sheep IgG (P < 0.05) (Fig. 2) The decline of whole animal activity was significantly greater at all time intervals in rats given antiFxlA than in those given normal sheep IgG. The percentage of the initial activity remaining after 24 h was 52.8±4.6% (n = 4) for those given anti-FxlA and 75.5±3.9% (n = 4) for those given normal sheep IgG, whereas at 5 d 11.9±2.9% (n = 4) and 38.9±4.8% (n = 4), respectively remained (P < 0.001).
TKAb and GAb of normal sheep IgG and anti-FxlA. Nonspecific contamination of the kidneys with normal sheep IgG in 19 rats injected with labeled normal sheep IgG was shown to be directly proportional to the blood concentration of sheep IgG (r = 0.96, log y = 0. 1642 + 0.0034x, P < 0.001, where x = sheep IgG micrograms per milliliter rat blood and y = sheep IgG micrograms per two kidneys) (Fig. 3) (Fig. 4) . The kinetics of GAb were similar to those of TKAb although GAb assumed a greater proportion of TKAb with time. None of these rats became proteinuric within 5 d.
Relationship of antibody deposition to the development of proteinuria. In 38 rats injected with doses of anti-FxlA IgG ranging from 5 to 35 mg, 24-h urine protein excretion was measured before determination of TKAb on day 5. The upper 99% confidence limit of normal urine protein excretion determined in 20 normal, age-matched rats of similar weight was 3.5 mg/ 24 h. Fig. 5 shows the relationship between urine protein excretion and the amount of antibody deposited. Most rats (23/27) with TKAb of 200 ,ug/2 kidneys or more had increased urine protein excretion (Fig. 5) . Of 11 rats with TKAb of <200 ,tg/2 kidneys, only 3 had mildly elevated urine protein excretion (Fig. 5) . later, no effect on TKAb as compared to controls was observed on day 5. (Controls, 101.6+17.3; methylprednisolone, 96.8±10.5; chlorpheniramine maleate, 102.7±10.7; cyproheptadine, 87.5±5.4 jig IgG/2 kidneys; n = 6 for each group. Analysis of variance P > 0.05). In addition, no effect of methylprednisolone or vasoactive amine blockers on the localization of immune deposits was noted by IF.
DISCUSSION
Our previous studies in this model, and in autologous immune complex nephropathy (Heymann nephritis), have shown that intrinsic properties of the glomerulus are critical determinants of subepithelial deposit formation, and that these deposits may form in situ in the absence ofcirculating immune complexes (7, 10, 11) as first suggested by Van Damme et al. (9) . to produce linear staining or proteinuria produced by 10 mg of nephrotoxic serum and by absorption with purified GBM as reported (10) . The observation that binding was not increased by sonic disruption of glomeruli suggests that binding occurred largely on readily accessible sites in the glomerulus. This conclusion is consistent with the IF results shown. In contrast, anti-GBM binding in vitro was increased by disruption of glomeruli. These results provide quantitative confirmation of earlier studies demonstrating direct binding of antibody to sections of normal rat glomeruli using IF and immunoenzymatic ultrastructural techniques (9, 29) .
The disappearance kinetics of normal IgG from the circulation corresponded closely to results of other studies (30) (31) (32) (31) . In contrast, deposits in PHN are exclusively subepithelial (8) (9) (10) (11) 15) , increase over days and are not altered by steroid administration. While the kinetic data on glomerular antibody deposition reported here do not absolutely exclude a circulating immune complex deposition mechanism, they are difficult to reconcile with this hypothesis. Considered together with the demonstration of direct binding of anti-FxlA to isolated glomeruli and the earlier production of subepithelial deposits in situ in the isolated perfused rat kidney (10), the in vivo glomerular antibody binding measured seems most compatible with the in situ interaction of antibody with antigenic determinants in the normal glomerular capillary wall (9, 10) .
The kinetics of glomerular antibody binding in PHN differ markedly from those in nephrotoxic nephritis in which deposits also result from interaction of free antibody with glomerular antigens. In nephrotoxic nephritis binding is maximal within 1 h of a single intravenous injection of anti-GBM antibody and declines thereafter, whereas proteinuria occurs almost immediately (12, 35) . In PHN only 35% ofthe total antibody bound by 5 d had deposited in 30 min, and proteinuria occurred only after 4-5 d of continued deposit formation. The striking difference between the two models suggests that the unique course of in vivo antibody deposition in PHN cannot be explained solely by simple binding of circulating antibody to a fixed glomerular antigen as occurs in nephrotoxic nephritis or in the isolated glomerulus.
Several possible explanations for these kinetic results warrant consideration. Most studies conclude that antibody binding in nephrotoxic nephritis occurs in the lamina densa or more proximal layers of the GBM (36, 37) and the uninterrupted linear pattern of deposition suggests relatively uniform access of antibody to antigen. In PHN, the much slower rate of antibody binding and the earliest appearance of granular deposits in filtration slit pores, where flow is believed to be highest (10, 38) , may reflect a limited ability of IgG to penetrate uniformly to the epithelial surface of the capillary wall (39) . Alternatively, antibody may have relatively free access to antigenic sites but binding may be limited by the small quantities of available antigen and further binding would depend on availability of new antigen derived either from de novo synthesis or accretion from the circulation. Finally, the possibility that deposit growth proceeds by a layering mechanism, in which glomerular binding of an initial divalent antibody leads to binding of circulating antigen in free or immune complex form followed by more antibody binding, is attractive but seems less likely in view of the small amount of circulating antigen (4, 5) , the lack of demonstrable antigen in deposits by IF (10, 11) , and the relatively large increase in glomerular-bound antibody (24 gg) from day 2 to 5.
Despite differences in the kinetics of immune deposition in PHN and nephrotoxic nephritis, the relationship between the total amount of antibody deposited and proteinuria appears similar in the two models. (Recent studies of PHN in immunosuppressed rats have shown that the small amounts of host IgG present in some capillary loops of some animals on day 5 in PHN are not essential to the development of proteinuria [unpublished observations.]) In this study an apparent proteinuric threshold of about 200 ag TKAb/2 kidneys was defined. This figure is comparable to those of Unanue and Dixon (12) who found 150 and 175 jug/2 kidneys of kidney-fixing duck and rabbit nephrotoxic antibody, respectively, were required to induce proteinuria in the rat although the amount that was actually bound to glomeruli is not known. By direct measurement we found that only 20-44% of TKAb was glomerular bound. The reason for this discrepancy between TKAb and GAb is unclear. Our calculations of GAb assume 38,000 glomeruli per rat kidney (24, 25) . Calculations based on a larger number of glomeruli per rat kidney (24, 25) could slightly reduce this discrepancy between TKAb and GAb, but there remains a significant amount of antibody apparently bound to extraglomerular renal structures or trapped in the interstitial space that is not readily appreciated by IF (40) .
This study provides new quantitative data on the kinetics of antibody deposition to form subepithelial immune deposits in PHN and documents the lack of effect ofvasoactive amine blockade and steroid therapy on this process. In addition, the amount of antibody deposition required to induce proteinuria has been defined and shown to be no greater than that which can be bound by glomerular antigen(s) when isolated glomeruli are incubated with anti-FxlA in vitro. Although the PHN model may bear a superficial resemblance to nephritis induced by anti-GBM antibody with respect to the mechanism of immune deposit formation and proteinuric threshold, these studies define a kinetic pattern of glomerular antibody binding that is unique to experimental membranous nephropathy. These findings suggest that, in addition to the interaction of antibody with tissue antigen, other factors are important in determining subepithelial immune deposit formationi.
